Association between atherogenic index of plasma and microvascular complications in patients with type 2 diabetes achieving low-density lipoprotein cholesterol targets: a real-world cohort study.
- 1Baoan Central Hospital of Shenzhen, Shenzhen, Guangdong, China.
- 2Department of Social Medicine and Health Management, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Abstract
Background
Despite achieving low-density lipoprotein cholesterol (LDL-C) targets, patients with type 2 diabetes mellitus (T2DM) remain at significant risk for microvascular complications. We aimed to investigate whether the atherogenic index of plasma (AIP), a marker of atherogenic dyslipidaemia, is associated with these complications in a real-world cohort of patients with controlled LDL-C.Methods
We conducted a retrospective cohort study using electronic health records from community health centres in Shenzhen, China (2018-2024). We included 16,469 participants with T2DM and LDL-C<2.6 mmol/L at baseline, categorising them into tertiles (T1-3) based on baseline AIP. The primary outcome was a composite of incident diabetic retinopathy, diabetic nephropathy, and diabetic peripheral neuropathy, identified via ICD-10 codes. We used multivariable Cox proportional hazards models to assess associations.Results
During a median follow-up of 4.6 years, 1,056 participants developed microvascular complications. We observed a graded association between AIP tertiles and the risk of microvascular complications. Participants in T3 had a significantly higher risk of total microvascular complications than those in T1 (hazard ratio (HR) = 1.34; 95% confidence interval (CI) = 1.15-1.56), while T2 showed no statistically significant increase in risk (HR = 1.10; 95% CI = 0.94-1.28). Specifically, compared to T1, T3 participants had significantly higher risks of diabetic nephropathy (HR = 1.62; 95% CI = 1.30-2.01) and diabetic peripheral neuropathy (HR = 1.39; 95% CI = 1.13-1.70), while no statistically significant association was found for diabetic retinopathy risk (HR = 1.23; 95% CI = 0.93-1.63). In contrast, compared with T1 participants, those in T2 had higher risks of nephropathy (HR = 1.28; 95% CI = 1.02-1.59), but no statistically significant associations were found for diabetic peripheral neuropathy or diabetic retinopathy.Conclusions
We found that AIP is independently associated with increased risk of microvascular complications, particularly diabetic nephropathy and diabetic peripheral neuropathy, even in T2DM patients achieving LDL-C targets. These results suggest that AIP may serve as a simple, lipid-based marker to help identify patients with residual microvascular risk beyond conventional LDL-C control.
Related
- Association between the fasting blood glucose to high-density lipoprotein cholesterol ratio and non-alcoholic fatty liver disease in Chinese adults: a secondary analysis
- Association of the triglyceride-to-high-density lipoprotein cholesterol ratio with kidney stone status: cross-sectional and machine-learning analyses
- Joint association of the cholesterol–high-density lipoprotein–glucose index and waist-to-height ratio with incident cardiovascular disease in a high-risk Chinese cohort
- Incidence of diabetes remission and association with microvascular and macrovascular complications in patients with newly diagnosed type 2 diabetes mellitus: a retrospective cohort study using real-world data in Thailand.
- Association between the cholesterol-high-density lipoprotein-glucose (CHG) index and albuminuria risk in diabetic patients
BibTeX
@article{zhang2026association,
title = {{Association between atherogenic index of plasma and microvascular complications in patients with type 2 diabetes achieving low-density lipoprotein cholesterol targets: a real-world cohort study.}},
author = {Shengchao Zhang and Yuzhao Shao and Min Li and Yuhan Wang and Hanbing Yu and Richang Cong and Zhenyuan Chen and Xiaoxv Yin and Ying Zhou and Huanhuan Ren},
journal = {Journal of global health},
year = {2026},
month = oct,
doi = {10.7189/jogh.16.04350},
url = {https://europepmc.org/article/MED/42924638},
note = {CC BY},
}
RIS
TY - JOUR
TI - Association between atherogenic index of plasma and microvascular complications in patients with type 2 diabetes achieving low-density lipoprotein cholesterol targets: a real-world cohort study.
AU - Shengchao Zhang
AU - Yuzhao Shao
AU - Min Li
AU - Yuhan Wang
AU - Hanbing Yu
AU - Richang Cong
AU - Zhenyuan Chen
AU - Xiaoxv Yin
AU - Ying Zhou
AU - Huanhuan Ren
PY - 2026
DA - 2026/10/23
JO - Journal of global health
DO - 10.7189/jogh.16.04350
UR - https://europepmc.org/article/MED/42924638
AB - Background Despite achieving low-density lipoprotein cholesterol (LDL-C) targets, patients with type 2 diabetes mellitus (T2DM) remain at significant risk for microvascular complications. We aimed to investigate whether the atherogenic index of plasma (AIP), a marker of atherogenic dyslipidaemia, is associated with these complications in a real-world cohort of patients with controlled LDL-C.Methods We conducted a retrospective cohort study using electronic health records from community health centres in Shenzhen, China (2018-2024). We included 16,469 participants with T2DM and LDL-C<2.6 mmol/L at baseline, categorising them into tertiles (T1-3) based on baseline AIP. The primary outcome was a composite of incident diabetic retinopathy, diabetic nephropathy, and diabetic peripheral neuropathy, identified via ICD-10 codes. We used multivariable Cox proportional hazards models to assess associations.Results During a median follow-up of 4.6 years, 1,056 participants developed microvascular complications. We observed a graded association between AIP tertiles and the risk of microvascular complications. Participants in T3 had a significantly higher risk of total microvascular complications than those in T1 (hazard ratio (HR) = 1.34; 95% confidence interval (CI) = 1.15-1.56), while T2 showed no statistically significant increase in risk (HR = 1.10; 95% CI = 0.94-1.28). Specifically, compared to T1, T3 participants had significantly higher risks of diabetic nephropathy (HR = 1.62; 95% CI = 1.30-2.01) and diabetic peripheral neuropathy (HR = 1.39; 95% CI = 1.13-1.70), while no statistically significant association was found for diabetic retinopathy risk (HR = 1.23; 95% CI = 0.93-1.63). In contrast, compared with T1 participants, those in T2 had higher risks of nephropathy (HR = 1.28; 95% CI = 1.02-1.59), but no statistically significant associations were found for diabetic peripheral neuropathy or diabetic retinopathy.Conclusions We found that AIP is independently associated with increased risk of microvascular complications, particularly diabetic nephropathy and diabetic peripheral neuropathy, even in T2DM patients achieving LDL-C targets. These results suggest that AIP may serve as a simple, lipid-based marker to help identify patients with residual microvascular risk beyond conventional LDL-C control.
SN - 2047-2978
SN - 2047-2986
ER -